Company: SXTPW
Filing Date: 2025-03-27
Form Type: S-1/A
Source: 0001013762-25-003353
Chunk: 229

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: S-1/A
Chunk 229
---
,810 |     |                           |      - |
| 2029       |     |         |  6,810 |     |                           |      - |
| Thereafter |     |         | 35,953 |     |                           |      - |
| Total      |     | $       | 70,003 |     | $                         | 47,287 |

The Company additionally has $ 40,172in capitalized patent expenses that will become amortizable as the patents they are associated with are awarded.

F-19

6. STOCKHOLDERS’ EQUITY

Pursuant to the Certificate of Incorporation of 60 Degrees Pharmaceuticals, Inc., the Company’s authorized shares consist of (a) 150,000,000shares of common stock, par value $ 0.0001per share and (b) 1,000,000shares of preferred stock, par value $ 0.0001per share, of which 80,965have been designated as Series A Non-Voting Convertible Preferred Stock (“Series A Preferred Stock”). As of December 31, 2024, 566,908shares of Common Stock and 76,480shares of Series A Preferred Stock are issued and outstanding.

Following stockholder approval in July 2024, on July 30, 2024, the Company filed an Amendment to the Certificate of Incorporation with the Secretary of State of Delaware to effect the 1:12 Reverse Stock Split of the issued and outstanding shares of the Company’s common stock, which was effective as of August 12, 2024. As of the effective time of the 1:12Reverse Stock Split, every twelve (12) issued and outstanding shares of the Company’s common stock were automatically combined and converted into one (1) issued and outstanding share of the Company’s common stock, reducing the number of shares of common stock outstanding from 21,219,937shares to 1,768,337shares (not including the effects of the 1:5Reverse Stock Split discussed below). No fractional shares of common stock were issued in connection with the Reverse Stock Split and all fractional shares were rounded up to the nearest whole share with respect to outstanding shares of common stock. The Company issued an additional 18,710shares of common stock on August 19, 2024 for rounding due to fractional shares ( 93,563not including the effects of the 1:5Reverse Stock Split discussed below).

Following stockholder approval in November 2024